• Home
  • Our Services
  • Our Team
  • Our Clients
  • Transactions
  • Contact Us

JSB Partners: Home

  • Team Members

  • North America
  • Michael Steiner
  • Tamar Howson
  • Richard Page
  • Jack Geltosky, Ph.D.
  • T. Scott Johnson, MD
  • Richmond Holden
  • Tricia Haut
  • Bridget Bridgman

  • Europe
  • Wolfgang Stoiber
  • Ulrich Pessara
  • Michel Gouy
  • Anya Ramalho

  • Asia
  • Klaus May

 

T. Scott Johnson, MD

T. Scott Johnson, MDScott Johnson is currently the Chief Medical Advisor and Vice President of New Business Ventures at The Medicines Company. Scott was a co-founder at JSB-Parters and currently serves in an Advisory role. Drawing on 30 years of experience as a physician and 17 years as a transaction advisor, Dr. Johnson has executed a wide range of transactions for pharmaceutical and biotechnology companies, North American and European venture firms, and private investors.

Experience
Prior to co-founding JSB-Partners, Dr. Johnson was a co-founder and senior managing director of MPM Capital, a private investment banking group focused on the biotechnology industry. His activities at MPM centered on private equity and corporate alliance transactions. Before MPM Capital, he was Associate Professor of Medicine and Director of the Sleep Disorders Laboratory at the University of Alabama School of Medicine, as well as a consultant for AFB-Parexel in Hamburg, Germany. Between 1979 and 1995 Dr. Johnson held academic positions at Harvard Medical School, Beth Israel Hospital and Brigham & Women's Hospital, all in Boston.

Education
Dr. Johnson earned a BS in Chemistry and Mathematics and an MD, Alpha Omega Alpha, at the University of Alabama. He is board certified in internal medicine, pulmonary diseases, critical care medicine, and sleep disorders.

Contact
tsjohnson@jsb-partners.com


© 2010 JSB-Partners, LP, Member SIPC, Member FINRA. Business Continuity Plan. All rights reserved.